Company Overview

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.

  • Name

    DSM-Firmenich AG

  • CEO

    Mr. Dimitri de Vreeze

  • Website

    www.dsm-firmenich.com

  • Sector

    Chemicals

  • Year Founded

    1902

Profile

  • Market Cap

    €31.57B

  • EV

    €35.23B

  • Shares Out

    265.28M

  • Revenue

    €12.46B

  • Employees

    27,926

Margins

  • Gross

    27.19%

  • EBITDA

    8.52%

  • Operating

    -0.26%

  • Pre-Tax

    -0.78%

  • Net

    -1.51%

  • FCF

    7.08%

Returns (5Yr Avg)

  • ROA

    7.21%

  • ROTA

    24.59%

  • ROE

    12.2%

  • ROCE

    3.94%

  • ROIC

    3.52%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €126.78

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €1,086M

  • Net Debt

    €3,496M

  • Debt/Equity

    0.21

  • EBIT/Interest

    -0.3

Growth (CAGR)

  • Rev 3Yr

    18.12%

  • Rev 5Yr

    7.94%

  • Rev 10Yr

    4.75%

  • Dil EPS 3Yr

    -53.69%

  • Dil EPS 5Yr

    -31.57%

  • Dil EPS 10Yr

    -4.22%

  • Rev Fwd 2Yr

    3.66%

  • EBITDA Fwd 2Yr

    13.76%

  • EPS Fwd 2Yr

    34.85%

  • EPS LT Growth Est

    40.77%

Dividends

  • Yield

  • Payout

    -33.05%

  • DPS

    €0.93

  • DPS Growth 3Yr

    -27.03%

  • DPS Growth 5Yr

    -16.52%

  • DPS Growth 10Yr

    -5.55%

  • DPS Growth Fwd 2Yr

    1.08%

ENXTAM:DSFIR